TY - JOUR
T1 - Relation of BMI and waist circumference with the risk of new-onset hyperuricemia in hypertensive patients
AU - Li, Q.
AU - Li, R.
AU - Zhang, S.
AU - Zhang, Y.
AU - Liu, M.
AU - Song, Y.
AU - Liu, C.
AU - Liu, L.
AU - Wang, X.
AU - Wang, B.
AU - Xu, X.
AU - Qin, X.
N1 - Publisher Copyright:
© 2022 Oxford University Press. All rights reserved.
PY - 2022/5/1
Y1 - 2022/5/1
N2 - Background: We aimed to evaluate the relationship of body mass index (BMI) and waist circumference (WC) with the risk of new-onset hyperuricemia, and examine possible effect modifies in general hypertensive patients. Methods: A total of 10 611 hypertensive patients with normal uric acid (UA) concentrations (<357 lmol/l) at baseline were included from the UA sub-study of the China Stroke Primary Prevention Trial. The primary outcome was new-onset hyperuricemia, defined as a UA concentration 417 lmol/l in men or 357 lmol/l in women at the exit visit. Results: During a median follow-up duration of 4.4 years, 1663 (15.7%) participants developed new-onset hyperuricemia. When analyzed separately, increased BMI (25 kg/m2 , quartile 3–4; OR, 1.46; 95% CI: 1.29–1.65), or increased WC (85 cm for females, quartile 3–4; OR, 1.24; 95% CI: 1.08–1.42; and 84 cm for males, quartile 3–4; OR, 1.30; 95% CI: 1.01–1.67) were each significantly associated with higher risk of new-onset hyperuricemia. When WC was forced into the model with BMI simultaneously, its significant association with new-onset hyperuricemia disappeared in females (<85 vs. 85 cm; OR, 0.96, 95% CI: 0.81–1.13) or males (84 vs. <84 cm; OR, 1.13; 95% CI: 0.84–1.52); however, BMI was still significantly related with new-onset hyperuricemia (25 vs. <25 kg/m2; OR, 1.48; 95% CI: 1.27–1.73). Moreover, the positive BMI & new-onset hyperuricemia association was more pronounced in participants with higher time-averaged on-treatment systolic blood pressure (median: <138.3 vs. 138.3 mmHg; P-interaction.041). Conclusions: Higher BMI, but not WC, is significantly and independently associated with an increased risk of new-onset hyperuricemia among hypertensive patients.
AB - Background: We aimed to evaluate the relationship of body mass index (BMI) and waist circumference (WC) with the risk of new-onset hyperuricemia, and examine possible effect modifies in general hypertensive patients. Methods: A total of 10 611 hypertensive patients with normal uric acid (UA) concentrations (<357 lmol/l) at baseline were included from the UA sub-study of the China Stroke Primary Prevention Trial. The primary outcome was new-onset hyperuricemia, defined as a UA concentration 417 lmol/l in men or 357 lmol/l in women at the exit visit. Results: During a median follow-up duration of 4.4 years, 1663 (15.7%) participants developed new-onset hyperuricemia. When analyzed separately, increased BMI (25 kg/m2 , quartile 3–4; OR, 1.46; 95% CI: 1.29–1.65), or increased WC (85 cm for females, quartile 3–4; OR, 1.24; 95% CI: 1.08–1.42; and 84 cm for males, quartile 3–4; OR, 1.30; 95% CI: 1.01–1.67) were each significantly associated with higher risk of new-onset hyperuricemia. When WC was forced into the model with BMI simultaneously, its significant association with new-onset hyperuricemia disappeared in females (<85 vs. 85 cm; OR, 0.96, 95% CI: 0.81–1.13) or males (84 vs. <84 cm; OR, 1.13; 95% CI: 0.84–1.52); however, BMI was still significantly related with new-onset hyperuricemia (25 vs. <25 kg/m2; OR, 1.48; 95% CI: 1.27–1.73). Moreover, the positive BMI & new-onset hyperuricemia association was more pronounced in participants with higher time-averaged on-treatment systolic blood pressure (median: <138.3 vs. 138.3 mmHg; P-interaction.041). Conclusions: Higher BMI, but not WC, is significantly and independently associated with an increased risk of new-onset hyperuricemia among hypertensive patients.
UR - http://www.scopus.com/inward/record.url?scp=85116393626&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85116393626&partnerID=8YFLogxK
U2 - 10.1093/qjmed/hcaa346
DO - 10.1093/qjmed/hcaa346
M3 - Article
C2 - 33486528
AN - SCOPUS:85116393626
SN - 1460-2725
VL - 115
SP - 271
EP - 278
JO - QJM
JF - QJM
IS - 5
ER -